{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:31:08Z","timestamp":1792992668387,"version":"4.5.0"},"reference-count":220,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["Knowledge Synthesis Grant, KRS 126594"],"award-info":[{"award-number":["Knowledge Synthesis Grant, KRS 126594"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Shifts in data sharing policy have increased researchers\u2019 access to individual participant data (IPD) from clinical studies. Simultaneously the number of IPD meta-analyses (IPDMAs) is increasing. However, rates of data retrieval have not improved. Our goal was to describe the challenges of retrieving IPD for an IPDMA and provide practical guidance on obtaining and managing datasets based on a review of the literature and practical examples and observations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched MEDLINE, Embase, and the Cochrane Library, until January 2019, to identify publications focused on strategies to obtain IPD. In addition, we searched pharmaceutical websites and contacted industry organizations for supplemental information pertaining to recent advances in industry policy and practice. Finally, we documented setbacks and solutions encountered while completing a comprehensive IPDMA and drew on previous experiences related to seeking and using IPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our scoping review identified 16 articles directly relevant for the conduct of IPDMAs. We present short descriptions of these articles alongside overviews of IPD sharing policies and procedures of pharmaceutical companies which display certification of Principles for Responsible Clinical Trial Data Sharing via Pharmaceutical Research and Manufacturers of America or European Federation of Pharmaceutical Industries and Associations websites. Advances in data sharing policy and practice affected the way in which data is requested, obtained, stored and analyzed.<\/jats:p>\n                    <jats:p>For our IPDMA it took 6.5\u2009years to collect and analyze relevant IPD and navigate additional administrative barriers. Delays in obtaining data were largely due to challenges in communication with study sponsors, frequent changes in data sharing policies of study sponsors, and the requirement for a diverse skillset related to research, administrative, statistical and legal issues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Knowledge of current data sharing practices and platforms as well as anticipation of necessary tasks and potential obstacles may reduce time and resources required for obtaining and managing data for an IPDMA. Sufficient project funding and timeline flexibility are pre-requisites for successful collection and analysis of IPD. IPDMA researchers must acknowledge the additional and unexpected responsibility they are placing on corresponding study authors or data sharing administrators and should offer assistance in readying data for sharing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12874-020-00964-6","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T08:04:00Z","timestamp":1589270640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide"],"prefix":"10.1186","volume":"20","author":[{"given":"Matthew","family":"Ventresca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger J.","family":"Sch\u00fcnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus","family":"Macbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie A.","family":"Akl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary H.","family":"Lyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Gloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"DiNisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Briel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"issue":"1","key":"964_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bpobgyn.2004.10.011","volume":"19","author":"MJ Clarke","year":"2005","unstructured":"Clarke MJ. Individual patient data meta-analyses. Best Pract Res Clin Obstet Gynaecol. 2005;19(1):47\u201355.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"964_CR2","first-page":"615","volume-title":"The handbook of research synthesis and meta-analysis","author":"HM Cooper","year":"2009","unstructured":"Cooper HM, Hedges LV, Valentine JC. The handbook of research synthesis and meta-analysis. 2nd ed. New York: Russell Sage Foundation xvi; 2009. p. 615.","edition":"2"},{"issue":"5","key":"964_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jclinepi.2006.09.009","volume":"60","author":"RD Riley","year":"2007","unstructured":"Riley RD, Simmonds MC, Look MP. Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. J Clin Epidemiol. 2007;60(5):431\u20139.","journal-title":"J Clin Epidemiol"},{"key":"964_CR4","doi-asserted-by":"publisher","first-page":"c221","DOI":"10.1136\/bmj.c221","volume":"340","author":"RD Riley","year":"2010","unstructured":"Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.","journal-title":"BMJ"},{"issue":"3","key":"964_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1191\/1740774505cn087oa","volume":"2","author":"MC Simmonds","year":"2005","unstructured":"Simmonds MC, et al. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials. 2005;2(3):209\u201317.","journal-title":"Clin Trials"},{"key":"964_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1745-6215-12-21","volume":"12","author":"C Tudur Smith","year":"2011","unstructured":"Tudur Smith C, et al. Individual participant data meta-analyses compared with meta-analyses based on aggregate data [abstract]. Trials. 2011;12:21\u20132.","journal-title":"Trials"},{"issue":"19","key":"964_CR7","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/sim.4780141902","volume":"14","author":"LA Stewart","year":"1995","unstructured":"Stewart LA, Clarke MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med. 1995;14(19):2057\u201379.","journal-title":"Stat Med"},{"issue":"1","key":"964_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0163278702025001006","volume":"25","author":"LA Stewart","year":"2002","unstructured":"Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof. 2002;25(1):76\u201397.","journal-title":"Eval Health Prof"},{"key":"964_CR9","first-page":"MR000007","volume":"9","author":"C Tudur Smith","year":"2016","unstructured":"Tudur Smith C, et al. Individual participant data meta-analyses compared with meta-analyses based on aggregate data. Cochrane Database Syst Rev. 2016;9:MR000007.","journal-title":"Cochrane Database Syst Rev"},{"key":"964_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2288-5-14","volume":"5","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Kuderer NM. The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol. 2005;5:14.","journal-title":"BMC Med Res Methodol"},{"issue":"17","key":"964_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMhle1309073","volume":"369","author":"MM Mello","year":"2013","unstructured":"Mello MM, et al. Preparing for responsible sharing of clinical trial data. N Engl J Med. 2013;369(17):1651\u20138.","journal-title":"N Engl J Med"},{"key":"964_CR12","unstructured":"Stewart LA, T.J., Clarke M. Chapter 18: Reviews of individual patient data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011; Available from: www.handbook.cochrane.org."},{"key":"964_CR13","doi-asserted-by":"publisher","first-page":"h1088","DOI":"10.1136\/bmj.h1088","volume":"350","author":"CL Vale","year":"2015","unstructured":"Vale CL, et al. Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study. BMJ. 2015;350:h1088.","journal-title":"BMJ"},{"issue":"11","key":"964_CR14","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jclinepi.2015.05.024","volume":"68","author":"JF Tierney","year":"2015","unstructured":"Tierney JF, et al. How individual participant data meta-analyses have influenced trial design, conduct, and analysis. J Clin Epidemiol. 2015;68(11):1325\u201335.","journal-title":"J Clin Epidemiol"},{"key":"964_CR15","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org\/handbook.","DOI":"10.1002\/9781119536604"},{"key":"964_CR16","doi-asserted-by":"publisher","first-page":"j1390","DOI":"10.1136\/bmj.j1390","volume":"357","author":"SJ Nevitt","year":"2017","unstructured":"Nevitt SJ, et al. Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review. BMJ. 2017;357:j1390.","journal-title":"BMJ"},{"issue":"19","key":"964_CR17","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1056\/NEJMsa1603542","volume":"376","author":"SA Coady","year":"2017","unstructured":"Coady SA, et al. Use of the National Heart, Lung, and Blood Institute data repository. N Engl J Med. 2017;376(19):1849\u201358.","journal-title":"N Engl J Med"},{"issue":"6","key":"964_CR18","doi-asserted-by":"publisher","first-page":"e100151","DOI":"10.1371\/journal.pone.0100151","volume":"9","author":"Y Huang","year":"2014","unstructured":"Huang Y, et al. Distribution and epidemiological characteristics of published individual patient data meta-analyses. PLoS One. 2014;9(6):e100151.","journal-title":"PLoS One"},{"key":"964_CR19","doi-asserted-by":"publisher","first-page":"d7762","DOI":"10.1136\/bmj.d7762","volume":"344","author":"I Ahmed","year":"2012","unstructured":"Ahmed I, Sutton AJ, Riley RD. Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey. BMJ. 2012;344:d7762.","journal-title":"BMJ"},{"key":"964_CR20","doi-asserted-by":"publisher","first-page":"e7570","DOI":"10.1136\/bmj.e7570","volume":"345","author":"V Rathi","year":"2012","unstructured":"Rathi V, et al. Sharing of clinical trial data among trialists: a cross sectional survey. BMJ. 2012;345:e7570.","journal-title":"BMJ"},{"issue":"5","key":"964_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/sim.2916","volume":"27","author":"AJ Sutton","year":"2008","unstructured":"Sutton AJ, Kendrick D, Coupland CA. Meta-analysis of individual- and aggregate-level data. Stat Med. 2008;27(5):651\u201369.","journal-title":"Stat Med"},{"key":"964_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2288-12-56","volume":"12","author":"G Abo-Zaid","year":"2012","unstructured":"Abo-Zaid G, Sauerbrei W, Riley RD. Individual participant data meta-analysis of prognostic factor studies: state of the art? BMC Med Res Methodol. 2012;12:56.","journal-title":"BMC Med Res Methodol"},{"key":"964_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/2046-4053-3-97","volume":"3","author":"GJ Jaspers","year":"2014","unstructured":"Jaspers GJ, Degraeuwe PL. A failed attempt to conduct an individual patient data meta-analysis. Syst Rev. 2014;3:97.","journal-title":"Syst Rev"},{"issue":"8","key":"964_CR24","doi-asserted-by":"publisher","first-page":"e0134826","DOI":"10.1371\/journal.pone.0134826","volume":"10","author":"C Tenopir","year":"2015","unstructured":"Tenopir C, et al. Changes in data sharing and data reuse practices and perceptions among scientists worldwide. PLoS One. 2015;10(8):e0134826.","journal-title":"PLoS One"},{"key":"964_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/1745-6215-15-384","volume":"15","author":"VK Rathi","year":"2014","unstructured":"Rathi VK, et al. Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey. Trials. 2014;15:384.","journal-title":"Trials"},{"issue":"1","key":"964_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13643-016-0334-1","volume":"5","author":"JS Ross","year":"2016","unstructured":"Ross JS. Clinical research data sharing: what an open science world means for researchers involved in evidence synthesis. Syst Rev. 2016;5(1):159.","journal-title":"Syst Rev"},{"issue":"12","key":"964_CR27","doi-asserted-by":"publisher","first-page":"e018647","DOI":"10.1136\/bmjopen-2017-018647","volume":"7","author":"C Ohmann","year":"2017","unstructured":"Ohmann C, et al. Sharing and reuse of individual participant data from clinical trials: principles and recommendations. BMJ Open. 2017;7(12):e018647.","journal-title":"BMJ Open"},{"issue":"1","key":"964_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.fertnstert.2017.11.034","volume":"109","author":"KT Barnhart","year":"2018","unstructured":"Barnhart KT, Legro RS, Scott RT Jr. Data sharing requirements: perspectives from three authors. Fertil Steril. 2018;109(1):44\u20137.","journal-title":"Fertil Steril"},{"issue":"6","key":"964_CR29","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1007\/s00330-017-5165-5","volume":"28","author":"F Sardanelli","year":"2018","unstructured":"Sardanelli F, et al. To share or not to share? Expected pros and cons of data sharing in radiological research. Eur Radiol. 2018;28(6):2328\u201335.","journal-title":"Eur Radiol"},{"issue":"6","key":"964_CR30","first-page":"538","volume":"18","author":"T Wu","year":"2018","unstructured":"Wu T, et al. Transparency and sharing individual participant data of clinical trials: a philosophical proposition about the medical study ethics and implications for clinical trials. [Chinese]. Chin J Evid Based Med. 2018;18(6):538\u201342.","journal-title":"Chin J Evid Based Med"},{"issue":"1","key":"964_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13063-016-1369-2","volume":"17","author":"AJ Vickers","year":"2016","unstructured":"Vickers AJ. Sharing raw data from clinical trials: what progress since we first asked \u201cWhose data set is it anyway?\u201d. Trials. 2016;17(1):227.","journal-title":"Trials"},{"key":"964_CR32","first-page":"1699","volume":"2014","author":"EA Bell","year":"2014","unstructured":"Bell EA, Ohno-Machado L, Grando MA. Sharing my health data: a survey of data sharing preferences of healthy individuals. AMIA Annu Symp Proc. 2014;2014:1699\u2013708.","journal-title":"AMIA Annu Symp Proc"},{"issue":"3","key":"964_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/1556264615592388","volume":"10","author":"PY Cheah","year":"2015","unstructured":"Cheah PY, et al. Perceived benefits, harms, and views about how to share data responsibly: a qualitative study of experiences with and attitudes toward data sharing among Research staff and community representatives in Thailand. J Empir Res Hum Res Ethics. 2015;10(3):278\u201389.","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"2","key":"964_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1355819617751555","volume":"23","author":"N Howe","year":"2018","unstructured":"Howe N, et al. Systematic review of participants\u2019 attitudes towards data sharing: a thematic synthesis. J Health Serv Res Policy. 2018;23(2):123\u201333.","journal-title":"J Health Serv Res Policy"},{"issue":"23","key":"964_CR35","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMsa1713258","volume":"378","author":"MM Mello","year":"2018","unstructured":"Mello MM, Lieou V, Goodman SN. Clinical trial participants\u2019 views of the risks and benefits of data sharing. N Engl J Med. 2018;378(23):2202\u201311.","journal-title":"N Engl J Med"},{"key":"964_CR36","volume-title":"European Medicines Agency policy on publication of clinical data for medicinal products for human use","author":"European Medicines Agency","year":"2014","unstructured":"European Medicines Agency. European Medicines Agency policy on publication of clinical data for medicinal products for human use. 2014; Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Other\/2014\/10\/WC500174796.pdf. [cited 2014 October 3]."},{"key":"964_CR37","volume-title":"Availability of Masked and De-identified Non-Summary Safety and Efficacy Data; Request for Comments","author":"Food and Drug Administration (FDA)","year":"2013","unstructured":"Food and Drug Administration (FDA). Availability of Masked and De-identified Non-Summary Safety and Efficacy Data; Request for Comments. 2013; Available from: https:\/\/federalregister.gov\/a\/2013-13083. [cited 2014 June 20]."},{"issue":"6","key":"964_CR38","doi-asserted-by":"publisher","first-page":"e1002315","DOI":"10.1371\/journal.pmed.1002315","volume":"14","author":"DB Taichman","year":"2017","unstructured":"Taichman DB, et al. Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors. PLoS Med. 2017;14(6):e1002315.","journal-title":"PLoS Med"},{"key":"964_CR39","unstructured":"Cancer Research UK. Submission of a data sharing and preservation strategy. 2009 June 1, 2015; Available from: http:\/\/www.cancerresearchuk.org\/prod_consump\/groups\/cr_common\/@fre\/@gen\/documents\/generalcontent\/cr_016308.pdf. Accessed 15 Apr 2020."},{"issue":"20","key":"964_CR40","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1056\/NEJMsb1708278","volume":"377","author":"R Kiley","year":"2017","unstructured":"Kiley R, et al. Data sharing from clinical trials - a Research Funder's perspective. N Engl J Med. 2017;377(20):1990\u20132.","journal-title":"N Engl J Med"},{"key":"964_CR41","volume-title":"Clinical Trials","year":"2018","unstructured":"International Committee of Medical Journal Editors. Clinical Trials. 2018; Available from: http:\/\/www.icmje.org\/recommendations\/browse\/publishing-and-editorial-issues\/clinical-trial-registration.html. [cited 2018 July 1]."},{"key":"964_CR42","doi-asserted-by":"publisher","first-page":"e7888","DOI":"10.1136\/bmj.e7888","volume":"345","author":"F Godlee","year":"2012","unstructured":"Godlee F, Groves T. The new BMJ policy on sharing data from drug and device trials. BMJ. 2012;345:e7888.","journal-title":"BMJ"},{"key":"964_CR43","unstructured":"PLOS Medicine. PLOS editorial and publishing policies; Available from: http:\/\/www.plosmedicine.org\/static\/policies.action;jsessionid=0CD27C4DE9841485620ED21B9E815D54#sharing. [cited 2014 July 1]."},{"key":"964_CR44","unstructured":"Scientific Data. Welcome to Scientific Data; Available from: http:\/\/www.nature.com\/sdata\/about. [cited 2014 July 1]."},{"key":"964_CR45","doi-asserted-by":"publisher","first-page":"h2373","DOI":"10.1136\/bmj.h2373","volume":"350","author":"E Loder","year":"2015","unstructured":"Loder E, Groves T. The BMJ requires data sharing on request for all trials. BMJ. 2015;350:h2373.","journal-title":"BMJ"},{"issue":"3","key":"964_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1503\/cmaj.140041","volume":"186","author":"J Fletcher","year":"2014","unstructured":"Fletcher J. New CMAJ policy on sharing data from clinical research. CMAJ. 2014;186(3):163.","journal-title":"CMAJ"},{"key":"964_CR47","volume-title":"Principles for resposible clinical trial data sharing: Our commitment to patients and researchers","author":"European Federation of Pharmaceutical Industries and Associations (EFPIA) and Pharmaceutical Research and Manufacturers of America (PhRMA)","year":"2013","unstructured":"European Federation of Pharmaceutical Industries and Associations (EFPIA) and Pharmaceutical Research and Manufacturers of America (PhRMA). Principles for resposible clinical trial data sharing: Our commitment to patients and researchers. 2013; Available from: http:\/\/phrma-docs.phrma.org\/sites\/default\/files\/pdf\/PhRMAPrinciplesForResponsibleClinicalTrialDataSharing.pdf. [cited 2018 July 30]."},{"issue":"4","key":"964_CR48","first-page":"4","volume":"11","author":"S Atzor","year":"2014","unstructured":"Atzor S, et al. Clinical trial data sharing: from principles to practical implementation - an industry model. Regul Rapporteur. 2014;11(4):4\u20137.","journal-title":"Regul Rapporteur"},{"issue":"8","key":"964_CR49","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jama.2015.292","volume":"313","author":"B Lo","year":"2015","unstructured":"Lo B. Sharing clinical trial data: maximizing benefits, minimizing risk. JAMA. 2015;313(8):793\u20134.","journal-title":"JAMA"},{"key":"964_CR50","doi-asserted-by":"publisher","first-page":"f4829","DOI":"10.1136\/bmj.f4829","volume":"347","author":"A O'Dowd","year":"2013","unstructured":"O'Dowd A. Drug industry pledge on access to trial data is met with scepticism. BMJ. 2013;347:f4829.","journal-title":"BMJ"},{"key":"964_CR51","doi-asserted-by":"publisher","first-page":"f5164","DOI":"10.1136\/bmj.f5164","volume":"347","author":"P Doshi","year":"2013","unstructured":"Doshi P. EFPIA-PhRMA's principles for clinical trial data sharing have been misunderstood. BMJ. 2013;347:f5164.","journal-title":"BMJ"},{"key":"964_CR52","unstructured":"Clinical Study Data Request. Study sponsors; Available from: https:\/\/www.clinicalstudydatarequest.com\/Study-Sponsors.aspx. [cited 2014 July 4]."},{"key":"964_CR53","volume-title":"Clinical trials data and information sharing","author":"Abbvie","year":"2014","unstructured":"Abbvie. Clinical trials data and information sharing. 2014; Available from: https:\/\/www.abbvie.com\/our-science\/clinical-trials\/clinical-trials-data-and-information-sharing\/data-and-information-sharing-with-qualified-researchers.html. [cited 2019 March 21]."},{"key":"964_CR54","volume-title":"Clinical Trial Transparency, Data Sharing and Disclosure Practices","author":"Amgen","year":"2019","unstructured":"Amgen. Clinical Trial Transparency, Data Sharing and Disclosure Practices 2019; Available from: https:\/\/www.amgen.com\/about\/how-we-operate\/policies-practices-and-disclosures\/ethical-research\/clinical-data-transparency-practices\/. [cited 2019 March 14]."},{"key":"964_CR55","volume-title":"About Astellas Clinical Study Results","author":"Astellas","year":"2018","unstructured":"Astellas. About Astellas Clinical Study Results. 2018; Available from: https:\/\/astellasclinicalstudyresults.com\/HCP.aspx. [cited 2019 March 1]."},{"key":"964_CR56","unstructured":"Bayer. Clinical trial transparency policy; Available from: http:\/\/pharma.bayer.com\/en\/innovation-partnering\/clinical-trials\/transparency-policy\/. [cited 2019 March 12]."},{"key":"964_CR57","volume-title":"Biogen clinical trial transparency and data sharing policy","author":"Biogen","year":"2018","unstructured":"Biogen. Biogen clinical trial transparency and data sharing policy. 2018; Available from: http:\/\/clinicalresearch.biogen.com\/. [cited 2018 July 30]."},{"key":"964_CR58","unstructured":"Boehringer-Ingelheim. Policy on transparency and publication of clinical study data: Registration of clinical studies, disclosure of results in publications and results databases and access to study data and documents; Available from: https:\/\/trials.boehringer-ingelheim.com\/content\/dam\/internet\/opu\/clinicaltrial\/com_EN\/documents\/Policy.pdf. [cited 2019 March 12]."},{"key":"964_CR59","volume-title":"Disclosure Commitment","author":"Bristol-Myers Squibb","year":"2018","unstructured":"Bristol-Myers Squibb. Disclosure Commitment. 2018; Available from: https:\/\/www.bms.com\/researchers-and-partners\/clinical-trials-and-research\/disclosure-commitment.html. [cited 2018 July 30]."},{"key":"964_CR60","volume-title":"Clinical trials data sharing","author":"Celgene","year":"2019","unstructured":"Celgene. Clinical trials data sharing. 2019; Available from: https:\/\/www.celgene.com\/research-development\/clinical-trials\/clinical-trials-data-sharing\/. [cited 2019 March 14]."},{"key":"964_CR61","unstructured":"Eisai Co. Ltd. Clinical trial disclosure; Available from: https:\/\/www.eisai.com\/company\/business\/research\/clinical\/index.html. [cited 2019 March 12]."},{"key":"964_CR62","volume-title":"Lilly announces increased access to clinical trials data for qualified researchers","author":"Eli Lilly and Company","year":"2014","unstructured":"Eli Lilly and Company. Lilly announces increased access to clinical trials data for qualified researchers. 2014; Available from: http:\/\/lilly.mediaroom.com\/index.php?s=9042&item=137313. [cited 2019 March 12]."},{"key":"964_CR63","volume-title":"Our Commitment to Responsible Clinical Trial Data Sharing","author":"EMD Serono","year":"2018","unstructured":"EMD Serono. Our Commitment to Responsible Clinical Trial Data Sharing. 2018; Available from: https:\/\/www.emdgroup.com\/en\/research\/our-approach-to-research-and-development\/healthcare\/clinical-trials\/commitment-responsible-data-sharing.html. [cited 2018 July 30]."},{"key":"964_CR64","volume-title":"GSK gives update on plans to share detailed clinical trial data as part of its commitment to transparency","author":"GlaxoSmithKline","year":"2013","unstructured":"GlaxoSmithKline. GSK gives update on plans to share detailed clinical trial data as part of its commitment to transparency. 2013; Available from: https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/gsk-gives-update-on-plans-to-share-detailed-clinical-trial-data-as-part-of-its-commitment-to-transparency\/. [cited 2019 March 12]."},{"key":"964_CR65","volume-title":"We are committed to data transparency","author":"Viiv Healthcare","year":"2019","unstructured":"Viiv Healthcare. We are committed to data transparency. 2019; Available from: https:\/\/www.viivhealthcare.com\/en-gb\/advancing-hiv-science-and-rd\/we-are-committed-to-data-transparency\/. [cited 2019 March 13]."},{"key":"964_CR66","volume-title":"Data access requests","author":"Pfizer","year":"2019","unstructured":"Pfizer. Data access requests. 2019; Available from: https:\/\/www.pfizer.com\/science\/clinical_trials\/trial_data_and_results\/data_requests. [cited 2019 March 1]."},{"key":"964_CR67","volume-title":"Clinical trials and results: Our data sharing commitments","author":"Sanofi","year":"2019","unstructured":"Sanofi. Clinical trials and results: Our data sharing commitments. 2019; Available from: https:\/\/www.sanofi.com\/en\/science-and-innovation\/clinical-trials-and-results\/our-data-sharing-commitments\/. [cited 2019 March 13]."},{"key":"964_CR68","volume-title":"Our commitment to transparency","author":"Shire","year":"2017","unstructured":"Shire. Our commitment to transparency. 2017; Available from: http:\/\/www.shiretrials.com\/en\/our-commitment-to-transparency\/data-sharing-with-researchers. [cited 2019 March 14]."},{"key":"964_CR69","volume-title":"A Tradition of Serving Patients With Integrity","author":"Takeda","year":"2015","unstructured":"Takeda. A Tradition of Serving Patients With Integrity. 2015; Available from: https:\/\/takedaclinicaltrials.com\/approach. [cited 2019 March 13]."},{"key":"964_CR70","volume-title":"UCB position statement on clinical study data transparency","author":"UCB","year":"2014","unstructured":"UCB. UCB position statement on clinical study data transparency. 2014; Available from: https:\/\/www.ucb.com\/our-science\/magazine\/detail\/article\/Transparency-supporting-responsible-data-sharing. [cited 2014 July 1]."},{"key":"964_CR71","volume-title":"Johnson & Johnson - Available Data","author":"The Yale University Open Data Access Project","year":"2018","unstructured":"The Yale University Open Data Access Project. Johnson & Johnson - Available Data. 2018; Available from: http:\/\/yoda.yale.edu\/jj-available-data. [cited 2018 July 30]."},{"key":"964_CR72","volume-title":"Clinical trial data transparency","author":"Janssen Global Services, L","year":"2018","unstructured":"Janssen Global Services, L Clinical trial data transparency. 2018; Available from: https:\/\/www.janssen.com\/clinical-trials\/transparency. [cited 2018 July 30]."},{"key":"964_CR73","volume-title":"Procedure on access to clinical trial data","author":"Merck","year":"2018","unstructured":"Merck. Procedure on access to clinical trial data. 2018; Available from: https:\/\/www.merck.com\/clinical-trials\/pdf\/ProcedureAccessClinicalTrialData.pdf. [cited 2019 March 22]."},{"key":"964_CR74","volume-title":"Review process for data sharing","author":"Purdue Pharma","year":"2018","unstructured":"Purdue Pharma. Review process for data sharing. 2018; Available from: http:\/\/purduepharma.com\/healthcare-professionals\/clinical-trials\/data-sharing\/. [cited 2019 March 21]."},{"key":"964_CR75","unstructured":"Roche. Roche global policy on sharing of clincal study information; Available from: https:\/\/www.roche.com\/dam\/jcr:1c46aa73-cea0-4b9b-8eaa-e9a788ed021b\/en\/roche_global_policy_on_sharing_of_clinical_study_information.pdf. [cited 2019 March 13]."},{"key":"964_CR76","volume-title":"Project Data Sphere","author":"Project Data Sphere LLC","year":"2020","unstructured":"Project Data Sphere LLC. Project Data Sphere. 2020; Available from: https:\/\/projectdatasphere.org\/projectdatasphere\/html\/home. [cited 2020 March 17]."},{"issue":"4","key":"964_CR77","doi-asserted-by":"publisher","first-page":"e010569","DOI":"10.1136\/bmjopen-2015-010569","volume":"6","author":"HJ Schunemann","year":"2016","unstructured":"Schunemann HJ, et al. Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. BMJ Open. 2016;6(4):e010569.","journal-title":"BMJ Open"},{"key":"964_CR78","volume-title":"How to request data","author":"Clinical Study Data Request","year":"2018","unstructured":"Clinical Study Data Request. How to request data. 2018; Available from: https:\/\/www.clinicalstudydatarequest.com\/Help\/Help-How-to-Request-Data.aspx. [cited 2018 July 30]."},{"issue":"7","key":"964_CR79","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"964_CR80","volume-title":"Our members","author":"Vivli","year":"2019","unstructured":"Vivli. Our members. 2019; Available from: https:\/\/vivli.org\/members\/ourmembers\/. [cited 2019 March 1]."},{"key":"964_CR81","volume-title":"Home","author":"European Federation of Pharmaceutical Industries and Associations (EFPIA)","year":"2020","unstructured":"European Federation of Pharmaceutical Industries and Associations (EFPIA). Home. 2020; Available from: https:\/\/www.efpia.eu\/. [cited 2020 March 17]."},{"key":"964_CR82","volume-title":"PhRMA","author":"Pharmaceutical Research and Manufacturers of America (PhRMA)","year":"2020","unstructured":"Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA. 2020; Available from: https:\/\/www.phrma.org\/en. [cited 2020 March 17]."},{"key":"964_CR83","volume-title":"Sharing clinical trial information","author":"European Federation of Pharmaceutical Industries and Associations (EFPIA)","year":"2018","unstructured":"European Federation of Pharmaceutical Industries and Associations (EFPIA). Sharing clinical trial information. 2018; Available from: https:\/\/www.efpia.eu\/about-medicines\/development-of-medicines\/clinical-trials\/sharing-clinical-trial-information\/. [cited 2018 July 30]."},{"key":"964_CR84","volume-title":"PhRMA Principles for Responsible Clinical Trial Data Sharing \u2013 Certifications","author":"Pharmaceutical Research and Manufacturers of America (PhRMA)","year":"2017","unstructured":"Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA Principles for Responsible Clinical Trial Data Sharing \u2013 Certifications. 2017; Available from: https:\/\/www.phrma.org\/codes-and-guidelines\/phrma-principles-for-responsible-clinical-trial-data-sharing-certifications. [cited 2018 July 28]."},{"key":"964_CR85","volume-title":"Sponsor Specific Details: Astellas","author":"Clinical Study Data Request","year":"2019","unstructured":"Clinical Study Data Request. Sponsor Specific Details: Astellas. 2019; Available from: https:\/\/www.clinicalstudydatarequest.com\/Study-Sponsors\/Study-Sponsors-Astellas.aspx. [cited 2019 March 1]."},{"key":"964_CR86","volume-title":"Clinical trial data sharing","author":"Chugai Pharmaceutical Co. Ltd","year":"2018","unstructured":"Chugai Pharmaceutical Co. Ltd. Clinical trial data sharing. 2018; Available from: https:\/\/www.chugai-pharm.co.jp\/english\/profile\/rd\/guideline\/ctds_request.html. [cited 2019 March 12]."},{"issue":"5","key":"964_CR87","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1056\/NEJMsr1302541","volume":"369","author":"P Nisen","year":"2013","unstructured":"Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med. 2013;369(5):475\u20138.","journal-title":"N Engl J Med"},{"key":"964_CR88","volume-title":"Data transparency","author":"GlaxoSmithKline","year":"2014","unstructured":"GlaxoSmithKline. Data transparency. 2014; Available from: https:\/\/www.gsk.com\/en-gb\/research\/our-approach\/trials-in-people\/data-transparency\/. [cited 2019 March 12]."},{"key":"964_CR89","volume-title":"Novartis Position on Clinical Study Transparency \u2013 Clinical Study Registration, Results Reporting and Data Sharing","author":"Novartis","year":"2016","unstructured":"Novartis. Novartis Position on Clinical Study Transparency \u2013 Clinical Study Registration, Results Reporting and Data Sharing. 2016; Available from: https:\/\/www.novartis.com\/sites\/www.novartis.com\/files\/clinical-trial-data-transparency.pdf. [cited 20189 March 12]."},{"key":"964_CR90","volume-title":"Disclosure of Clinical Study Data","author":"Sumitomo Dainippon Pharma","year":"2018","unstructured":"Sumitomo Dainippon Pharma. Disclosure of Clinical Study Data. 2018; Available from: https:\/\/www.ds-pharma.com\/rd\/clinical\/clinical_study_data.html. [cited 2019 March 13]."},{"key":"964_CR91","unstructured":"Yale University Open Data Access (YODA) Project. How to request data; Available from: https:\/\/yoda.yale.edu\/how-request-data. [cited 2019 March 13]."},{"key":"964_CR92","volume-title":"Johnson & Johnson Announces Clinical Trial Data Sharing Agreement with Yale School of Medicine","author":"Johnson & Johnson","year":"2014","unstructured":"Johnson & Johnson. Johnson & Johnson Announces Clinical Trial Data Sharing Agreement with Yale School of Medicine. 2014; Available from: http:\/\/www.jnj.com\/news\/all\/johnson-and-johnson-announces-clinical-trial-data-sharing-agreement-with-yale-school-of-medicine. [cited 2014 July 1]."},{"key":"964_CR93","volume-title":"Give the data to the people","author":"HM Krumholz","year":"2014","unstructured":"Harlan M. Krumholz. Give the data to the people. 2014; Available from: http:\/\/www.nytimes.com\/2014\/02\/03\/opinion\/give-the-data-to-the-people.html?_r=0. [cited 2014 July 4]."},{"key":"964_CR94","volume-title":"Biogen clinical trial transparency and data sharing policy","author":"Biogen","year":"2019","unstructured":"Biogen. Biogen clinical trial transparency and data sharing policy. 2019; Available from: http:\/\/clinicalresearch.biogen.com\/. [cited 2019 March 5]."},{"key":"964_CR95","volume-title":"Clinical trial data sharing policy","author":"Celgene","year":"2017","unstructured":"Celgene. Clinical trial data sharing policy. 2017; Available from: https:\/\/media.celgene.com\/content\/uploads\/clinical-trial-data-sharing-policy.pdf. [cited 2019 March 14]."},{"key":"964_CR96","volume-title":"Clinical Trial Information Disclosure","author":"Daiichi-Sankyo","year":"2018","unstructured":"Daiichi-Sankyo. Clinical Trial Information Disclosure. 2018; Available from: https:\/\/www.daiichisankyo.com\/rd\/our_approach\/clinical_studies\/index.html. [cited 2018 July 20]."},{"key":"964_CR97","volume-title":"Clinical Trials Data Access - Independent Review Panel Charter","author":"Pfizer","year":"2014","unstructured":"Pfizer. Clinical Trials Data Access - Independent Review Panel Charter. 2014; Available from: https:\/\/www.pfizer.com\/files\/research\/research_clinical_trials\/Independent_Review_Panel_Charter_01312014.pdf. [cited 2019 March 21]."},{"key":"964_CR98","volume-title":"AstraZeneca Group of Companies \u2013 Data Request Portal","author":"AstraZeneca","year":"2018","unstructured":"AstraZeneca. AstraZeneca Group of Companies \u2013 Data Request Portal. 2018; Available from: https:\/\/astrazenecagroup-dt.pharmacm.com\/DT\/Home. [cited 2018 July 20]."},{"key":"964_CR99","volume-title":"AstraZeneca Clinical Trial Transparency and External Sharing of Individual Patient-Level Data","author":"N Andrews","year":"2015","unstructured":"Natalie Andrews. AstraZeneca Clinical Trial Transparency and External Sharing of Individual Patient-Level Data. 2015; Available from: https:\/\/www.phusewiki.org\/docs\/Conference%202015%20PP%20Papers\/PP17.pdf. [cited 2018 July 20]."},{"key":"964_CR100","volume-title":"Disclosure Commitment","author":"AstraZeneca","year":"2019","unstructured":"AstraZeneca. Disclosure Commitment. 2019; Available from: https:\/\/astrazenecagrouptrials.pharmacm.com\/ST\/Submission\/Disclosure. [cited 2019 March 21]."},{"key":"964_CR101","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ahj.2015.11.002","volume":"172","author":"MJ Pencina","year":"2016","unstructured":"Pencina MJ, et al. Supporting open access to clinical trial data for researchers: the Duke Clinical Research Institute-Bristol-Myers Squibb supporting open access to researchers initiative. Am Heart J. 2016;172:64\u20139.","journal-title":"Am Heart J"},{"key":"964_CR102","volume-title":"Clinical trial transparency statement","author":"Chiesi Group","year":"2018","unstructured":"Chiesi Group. Clinical trial transparency statement. 2018; Available from: https:\/\/www.chiesi.com\/en\/research-and-development\/clinical-trial-transparency-and-data-sharing\/. [cited 2019 March 21]."},{"key":"964_CR103","unstructured":"EMD Serono. Responsible data sharing instruction document; Available from: https:\/\/www.emdgroup.com\/content\/dam\/web\/corporate\/non-images\/business-specifics\/healthcare\/US\/Responsible_Data_Sharing_Instruction_Document_US.pdf. [cited 2019 April 18]."},{"key":"964_CR104","volume-title":"User Registration","author":"The Menarini Group","year":"2018","unstructured":"The Menarini Group. User Registration. 2018; Available from: https:\/\/clinicaltrials.menarini.com\/en-US\/Home\/Datasharing. [cited 2018 July 30]."},{"key":"964_CR105","volume-title":"Datasharing","author":"The Menarini Group","year":"2018","unstructured":"The Menarini Group. Datasharing. 2018; Available from: https:\/\/clinicaltrials.menarini.com\/en-US\/Home\/Datasharing. [cited 2019 March 21]."},{"key":"964_CR106","unstructured":"Regeneron. Clinical Trial Disclosure & Data Transparency Policy Statements; Available from: https:\/\/errs.regeneron.com\/external\/DefaultBU1.aspx. [cited 2020 March 18]."},{"key":"964_CR107","volume-title":"Data request portal","author":"Servier","year":"2018","unstructured":"Servier. Data request portal. 2018; Available from: https:\/\/clinicaltrials.servier.com\/data-request-portal\/. [cited 2019 March 21]."},{"key":"964_CR108","volume-title":"Clinical trials","author":"Almirall","year":"2019","unstructured":"Almirall. Clinical trials. 2019; Available from: https:\/\/www.almirall.com\/en\/about-almirall\/research-and-development\/clinical-trials. [cited 2019 March 14]."},{"key":"964_CR109","volume-title":"Clinical Trial Data Sharing Request","author":"Amgen","year":"2019","unstructured":"Amgen. Clinical Trial Data Sharing Request 2019; Available from: https:\/\/www.amgen.com\/about\/how-we-operate\/policies-practices-and-disclosures\/ethical-research\/clinical-data-transparency-practices\/clinical-trial-data-sharing-request\/. [cited 2019 March 14]."},{"key":"964_CR110","volume-title":"Transparency","author":"Bial","year":"2014","unstructured":"Bial. Transparency. 2014; Available from: https:\/\/www.bial.com\/en\/r_d.2\/transparency.208\/transparency.a484.html. [cited 2019 March 14]."},{"key":"964_CR111","volume-title":"Clinical data sharing with researchers","author":"Grunenthal","year":"2018","unstructured":"Grunenthal. Clinical data sharing with researchers. 2018; Available from: https:\/\/www.grunenthal.com\/r-d-vision-mission\/clinical-trials\/data-sharing-clinical-trials. [cited 2019 March 21]."},{"key":"964_CR112","unstructured":"Leo Pharma. LEO Pharma's Position on Public Access to Clinical Trials Information. Available from: http:\/\/www.leo-pharma.com\/Home\/Research-and-Development\/Clinical-trial-disclosure\/LEO-Pharmas-position-on-transparency.aspx. [cited 2019 March 14]."},{"key":"964_CR113","unstructured":"Leo Pharma. How to get access to anonymised patient-level data. Available from: http:\/\/www.leo-pharma.com\/Home\/Research-and-Development\/Clinical-trial-disclosure\/Access-to-patient-level-data.aspx#Step_1:__Fasibility_assessment_by_LEO_Pharma. [cited 2019 March 14]."},{"key":"964_CR114","volume-title":"Policy for scientific publications and responsible clinical trial data sharing","author":"Lundbeck","year":"2018","unstructured":"Lundbeck. Policy for scientific publications and responsible clinical trial data sharing. 2018; Available from: https:\/\/www.lundbeck.com\/global\/brain-disorders\/research-and-development\/policy-for-scientific-publications-and-responsible-clinical-trial-data-sharing\/clinical-data-sharing. [cited 2019 March 14]."},{"key":"964_CR115","unstructured":"Novo Nordisk. How to access clinical trial datasets. Available from: https:\/\/www.novonordisk-trials.com\/how-access-clinical-trial-datasets. [cited 2019 March 14]."},{"key":"964_CR116","unstructured":"Novo Nordisk. Independent review board charter. Available from: https:\/\/www.novonordisk-trials.com\/sites\/novonordisk\/themes\/novo\/img\/document\/Independent%20Review%20Board%20Charter.pdf. [cited 2019 March 14]."},{"key":"964_CR117","unstructured":"Orion Corporation. Ethics in the Clinical Research Phase. Available from: https:\/\/www.orion.fi\/en\/Orion-group\/Sustainability\/policies\/pharmaceutical-rd-ethics-policy\/ethics-in-clinical-research\/. [cited 2019 March 14]."},{"key":"964_CR118","volume-title":"For researchers: Overview of researcher access to patient-level data","author":"Otsuka Pharmaceutical Co. Ltd","year":"2019","unstructured":"Otsuka Pharmaceutical Co. Ltd. For researchers: Overview of researcher access to patient-level data 2019; Available from: https:\/\/clinical-trials.otsuka.com\/For-Researchers.aspx. [cited 2019 March 14]."},{"key":"964_CR119","volume-title":"Responsibility highlights report 2017","author":"Vifor Pharma","year":"2018","unstructured":"Vifor Pharma. Responsibility highlights report 2017 2018. Available from: http:\/\/www.viforpharma.com\/~\/media\/Files\/V\/Vifor-Pharma\/documents\/en\/responsibility\/Vifor_Pharma_CSR_Report_2017.pdf. [cited 2019 March 14]."},{"key":"964_CR120","volume-title":"Review of requests","author":"Clinical Study Data Request","year":"2018","unstructured":"Clinical Study Data Request. Review of requests. 2018; Available from: https:\/\/www.clinicalstudydatarequest.com\/Help\/Help-Review-of-Requests.aspx. [cited 2018 July 30]."},{"key":"964_CR121","unstructured":"Clinical Study Data Request. Independent review panel charter. Available from: https:\/\/clinicalstudydatarequest.com\/Documents\/Independent_Review_Panel_Charter.pdf. [cited 2018 August 1]."},{"key":"964_CR122","volume-title":"Biogen","author":"Vivli","year":"2019","unstructured":"Vivli. Biogen. 2019. Available from: https:\/\/vivli.org\/ourmember\/biogen\/. [cited 2019 March 21]."},{"key":"964_CR123","volume-title":"Bristol-Myers Squibb data sharing independent review committee (IRC) charter","author":"Duke Clinical Research Institute","year":"2017","unstructured":"Duke Clinical Research Institute. Bristol-Myers Squibb data sharing independent review committee (IRC) charter. 2017. Available from: https:\/\/dcri.org\/wp-content\/uploads\/2017\/10\/BMS_Charter_FINAL-approved-by-IRC-10.13.17-1.pdf. [cited 2019 March 21]."},{"key":"964_CR124","unstructured":"EMD Serono. Summary of EMD Serono's responsible data sharing policy. [cited 2019 March 22]."},{"key":"964_CR125","volume-title":"Requesting access to clinical data","author":"Grunenthal","year":"2018","unstructured":"Grunenthal. Requesting access to clinical data. 2018. Available from: https:\/\/www.grunenthal.com\/-\/media\/projects\/corporatewebsite\/com\/pdf\/content_clincialtrial-portal\/2018-11-02_sdn-pubdiscl-access_requesting-access-to-clinical-data.pdf?la=en&hash=2D683A66BEA23C98044D2833D732713B581E2929. [cited 2019 March 21]."},{"key":"964_CR126","volume-title":"Procedures to Guide External Investigator Access to Clinical Trial Data","author":"Yale University Open Data Access (YODA) Project","year":"2016","unstructured":"Yale University Open Data Access (YODA) Project. Procedures to Guide External Investigator Access to Clinical Trial Data. 2016. Available from: http:\/\/yoda.yale.edu\/sites\/default\/files\/files\/YODA%20Project%20Data%20Release%20Procedures%20June%202016.pdf. [cited 2018 August 1]."},{"key":"964_CR127","volume-title":"Regeneron Mission Statement & Purpose of Investigator-Initiated Study Program","author":"Regeneron","year":"2020","unstructured":"Regeneron. Regeneron Mission Statement & Purpose of Investigator-Initiated Study Program. 2020; Available from: https:\/\/errs.regeneron.com\/external\/DefaultBU1.aspx. [cited 2020 March 17]."},{"issue":"1","key":"964_CR128","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1740774513514497","volume":"11","author":"JA Berlin","year":"2014","unstructured":"Berlin JA, et al. Bumps and bridges on the road to responsible sharing of clinical trial data. Clin Trials. 2014;11(1):7\u201312.","journal-title":"Clin Trials"},{"key":"964_CR129","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jclinepi.2017.12.014","volume":"98","author":"JR Polanin","year":"2018","unstructured":"Polanin JR. Efforts to retrieve individual participant data sets for use in a meta-analysis result in moderate data sharing but many data sets remain missing. J Clin Epidemiol. 2018;98:157\u20139.","journal-title":"J Clin Epidemiol"},{"key":"964_CR130","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jclinepi.2018.10.006","volume":"106","author":"JR Polanin","year":"2019","unstructured":"Polanin JR, Terzian M. A data-sharing agreement helps to increase researchers\u2019 willingness to share primary data: results from a randomized controlled trial. J Clin Epidemiol. 2019;106:60\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"964_CR131","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jrsm.1208","volume":"7","author":"JR Polanin","year":"2016","unstructured":"Polanin JR, Williams RT. Overcoming obstacles in obtaining individual participant data for meta-analysis. Res Synth Methods. 2016;7(3):333\u201341.","journal-title":"Res Synth Methods"},{"key":"964_CR132","doi-asserted-by":"publisher","unstructured":"Tierney JF, Vale C, Riley R, Smith CT, Stewart L, Clarke M, et al. Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use. PLoS Med. 2015;12(7):e1001855. https:\/\/doi.org\/10.1371\/journal.pmed.1001855. Accessed 15 Apr 2020.","DOI":"10.1371\/journal.pmed.1001855"},{"issue":"1","key":"964_CR133","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13063-016-1238-z","volume":"17","author":"AA Veroniki","year":"2016","unstructured":"Veroniki AA, et al. Contacting authors to retrieve individual patient data: study protocol for a randomized controlled trial. Trials. 2016;17(1):138.","journal-title":"Trials"},{"key":"964_CR134","first-page":"MR000027","volume":"11","author":"T Young","year":"2011","unstructured":"Young T, Hopewell S. Methods for obtaining unpublished data. Cochrane Database Syst Rev. 2011;11:MR000027.","journal-title":"Cochrane Database Syst Rev"},{"key":"964_CR135","unstructured":"Lefebvre C, M.E., Glanville J. Chapter 6: Searching for studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011; Available from: www.handbook.cochrane.org."},{"key":"964_CR136","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2046-4053-2-31","volume":"2","author":"N Wolfe","year":"2013","unstructured":"Wolfe N, Gotzsche PC, Bero L. Strategies for obtaining unpublished drug trial data: a qualitative interview study. Syst Rev. 2013;2:31.","journal-title":"Syst Rev"},{"key":"964_CR137","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jclinepi.2019.05.031","volume":"113","author":"AA Veroniki","year":"2019","unstructured":"Veroniki AA, et al. Retrieval of individual patient data depended on study characteristics: a randomized controlled trial. J Clin Epidemiol. 2019;113:176\u201388.","journal-title":"J Clin Epidemiol"},{"key":"964_CR138","unstructured":"Clinical Study Data Request. Our mission. 2019; Available from: https:\/\/clinicalstudydatarequest.com\/Default.aspx. [cited 2019 April 1]."},{"issue":"4","key":"964_CR139","doi-asserted-by":"publisher","first-page":"e003307","DOI":"10.1161\/JAHA.116.003307","volume":"5","author":"K Murugiah","year":"2016","unstructured":"Murugiah K, et al. Availability of clinical trial data from industry-sponsored cardiovascular trials. J Am Heart Assoc. 2016;5(4):e003307.","journal-title":"J Am Heart Assoc"},{"key":"964_CR140","volume-title":"DARS guidance","author":"NHS Digital","year":"2019","unstructured":"NHS Digital. DARS guidance. 2019; Available from: https:\/\/digital.nhs.uk\/services\/data-access-request-service-dars\/dars-guidance. [cited 2019 February 22]."},{"key":"964_CR141","volume-title":"Data Access Request Service (DARS): process","author":"NHS Digital","year":"2019","unstructured":"NHS Digital. Data Access Request Service (DARS): process. 2019; Available from: https:\/\/digital.nhs.uk\/services\/data-access-request-service-dars\/data-access-request-service-dars-process. [cited 2019 February 22]."},{"key":"964_CR142","volume-title":"Metrics","author":"Clinical Study Data Request","year":"2019","unstructured":"Clinical Study Data Request. Metrics. 2019; Available from: https:\/\/clinicalstudydatarequest.com\/Metrics.aspx. [cited 2019 April 1]."},{"issue":"1","key":"964_CR143","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12916-015-0525-y","volume":"13","author":"N Geifman","year":"2015","unstructured":"Geifman N, et al. Opening clinical trial data: Are the voluntary data-sharing portals enough? BMC Med. 2015;13(1):280.","journal-title":"BMC Med"},{"key":"964_CR144","volume-title":"Members","author":"Pharmaceutical Research and Manufacturers of America (PhRMA)","year":"2019","unstructured":"Pharmaceutical Research and Manufacturers of America (PhRMA). Members. 2019; Available from: https:\/\/www.phrma.org\/about\/members. [cited 2019 March 4]."},{"key":"964_CR145","volume-title":"Membership","author":"European Federation of Pharmaceutical Industries and Associations (EFPIA)","year":"2019","unstructured":"European Federation of Pharmaceutical Industries and Associations (EFPIA). Membership. 2019; Available from: https:\/\/www.efpia.eu\/about-us\/membership\/. [cited 2019 March 4]."},{"issue":"1","key":"964_CR146","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1186\/s12916-018-1154-z","volume":"16","author":"AM Hopkins","year":"2018","unstructured":"Hopkins AM, Rowland A, Sorich MJ. Data sharing from pharmaceutical industry sponsored clinical studies: Audit of data availability. BMC Med. 2018;16(1):1154.","journal-title":"BMC Med"},{"key":"964_CR147","volume-title":"EFPIA-PHRMA Princples for responsible clinical trial data sharing report on the 2016 member company survey.","author":"Pharmaceutical Research and Manufacturers of America (PhRMA)","year":"2017","unstructured":"Pharmaceutical Research and Manufacturers of America (PhRMA). EFPIA-PHRMA Princples for responsible clinical trial data sharing report on the 2016 member company survey. 2017; Available from: https:\/\/www.efpia.eu\/media\/288603\/efpia-phrma-report-on-the-2016-member-company-survey-on-the-joint-principles-for-responsible-clinical-trial-data-sharing.pdf. [cited 2019 March 4]."},{"key":"964_CR148","volume-title":"2018 Progress Report","author":"Vivli Center for Global Clinical Research Data","year":"2019","unstructured":"Vivli Center for Global Clinical Research Data. 2018 Progress Report. 2019; Available from: https:\/\/s3.amazonaws.com\/pageturnpro2.com\/Publications\/201812\/4485\/87942\/PDF\/131889563346378000_Vivli_AR_2018.pdf. [cited 2019 April 1]."},{"issue":"9913","key":"964_CR149","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0140-6736(13)62296-5","volume":"383","author":"AW Chan","year":"2014","unstructured":"Chan AW, et al. Increasing value and reducing waste: addressing inaccessible research. Lancet. 2014;383(9913):257\u201366.","journal-title":"Lancet"},{"issue":"12","key":"964_CR150","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.tips.2013.10.006","volume":"34","author":"P Doshi","year":"2013","unstructured":"Doshi P, Goodman SN, Ioannidis JP. Raw data from clinical trials: within reach? Trends Pharmacol Sci. 2013;34(12):645\u20137.","journal-title":"Trends Pharmacol Sci"},{"key":"964_CR151","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/1745-6215-12-249","volume":"12","author":"PC Gotzsche","year":"2011","unstructured":"Gotzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials. 2011;12:249.","journal-title":"Trials"},{"issue":"13","key":"964_CR152","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jama.2013.1299","volume":"309","author":"JS Ross","year":"2013","unstructured":"Ross JS, Krumholz HM. Ushering in a new era of open science through data sharing: the wall must come down. JAMA. 2013;309(13):1355\u20136.","journal-title":"JAMA"},{"issue":"2","key":"964_CR153","doi-asserted-by":"publisher","first-page":"e0118053","DOI":"10.1371\/journal.pone.0118053","volume":"10","author":"B Fecher","year":"2015","unstructured":"Fecher B, Friesike S, Hebing M. What drives academic data sharing? PLoS One. 2015;10(2):e0118053.","journal-title":"PLoS One"},{"issue":"4","key":"964_CR154","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/1745691613491579","volume":"8","author":"Nimh Collaborative Data Synthesis for Adolescent Depression Trials Study Team including","year":"2013","unstructured":"Nimh Collaborative Data Synthesis for Adolescent Depression Trials Study Team including, et al. Advancing Science Through Collaborative Data Sharing and Synthesis. Perspect Psychol Sci. 2013;8(4):433\u201344.","journal-title":"Perspect Psychol Sci"},{"issue":"4","key":"964_CR155","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1056\/NEJMc1707245","volume":"377","author":"MR Sydes","year":"2017","unstructured":"Sydes MR, Ashby D. Data authorship as an incentive to data sharing. N Engl J Med. 2017;377(4):402.","journal-title":"N Engl J Med"},{"issue":"4","key":"964_CR156","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1056\/NEJMc1707245","volume":"377","author":"BE Bierer","year":"2017","unstructured":"Bierer BE, Crosas M, Pierce HH. Data authorship as an incentive to data sharing. N Engl J Med. 2017;377(4):402.","journal-title":"N Engl J Med"},{"issue":"6146","key":"964_CR157","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1126\/science.1241625","volume":"341","author":"F Berman","year":"2013","unstructured":"Berman F, Cerf V. Science priorities. Who will pay for public access to research data? Science. 2013;341(6146):616\u20137.","journal-title":"Science"},{"issue":"12","key":"964_CR158","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1001\/jama.2014.850","volume":"311","author":"EE Wilhelm","year":"2014","unstructured":"Wilhelm EE, Oster E, Shoulson I. Approaches and costs for sharing clinical research data. JAMA. 2014;311(12):1201\u20132.","journal-title":"JAMA"},{"issue":"5","key":"964_CR159","doi-asserted-by":"publisher","first-page":"e1002304","DOI":"10.1371\/journal.pmed.1002304","volume":"14","author":"CS Zhu","year":"2017","unstructured":"Zhu CS, et al. Data sharing in clinical trials: an experience with two large cancer screening trials. PLoS Med. 2017;14(5):e1002304.","journal-title":"PLoS Med"},{"key":"964_CR160","doi-asserted-by":"publisher","first-page":"k400","DOI":"10.1136\/bmj.k400","volume":"360","author":"F Naudet","year":"2018","unstructured":"Naudet F, et al. Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: Survey of studies published in the BMJ and PLOS Medicine. BMJ. 2018;360:k400.","journal-title":"BMJ"},{"key":"964_CR161","volume-title":"Establishing incentives and changing cultures to support data access","author":"M Bobrow","year":"2014","unstructured":"Martin Bobrow, et al. Establishing incentives and changing cultures to support data access. 2014; Available from: https:\/\/wellcome.ac.uk\/sites\/default\/files\/establishing-incentives-and-changing-cultures-to-support-data-access-eagda-may14.pdf. [cited 2019 March 20]."},{"issue":"12","key":"964_CR162","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJMp1608086","volume":"375","author":"F Rockhold","year":"2016","unstructured":"Rockhold F, Nisen P, Freeman A. Data sharing at a crossroads. N Engl J Med. 2016;375(12):1115\u20137.","journal-title":"N Engl J Med"},{"issue":"6399","key":"964_CR163","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1126\/science.361.6399.212","volume":"361","author":"J Kaiser","year":"2018","unstructured":"Kaiser J. A new portal for patient data. Science. 2018;361(6399):212.","journal-title":"Science"},{"issue":"Suppl 1","key":"964_CR164","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12874-016-0169-4","volume":"16","author":"K Tucker","year":"2016","unstructured":"Tucker K, et al. Protecting patient privacy when sharing patient-level data from clinical trials. BMC Med Res Methodol. 2016;16(Suppl 1):77.","journal-title":"BMC Med Res Methodol"},{"key":"964_CR165","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12916-015-0532-z","volume":"13","author":"C Tudur Smith","year":"2015","unstructured":"Tudur Smith C, et al. How should individual participant data (IPD) from publicly funded clinical trials be shared? BMC Med. 2015;13:298.","journal-title":"BMC Med"},{"key":"964_CR166","volume-title":"External guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use","author":"European Medicines Agency","year":"2018","unstructured":"European Medicines Agency. External guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use. 2018; Available from: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/external-guidance-implementation-european-medicines-agency-policy-publication-clinical-data_en-3.pdf. [cited 2020 March 18]."},{"issue":"6","key":"964_CR167","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2217\/cer-2017-0009","volume":"6","author":"KM Mazor","year":"2017","unstructured":"Mazor KM, et al. Stakeholders\u2019 views on data sharing in multicenter studies. J Comp Eff Res. 2017;6(6):537\u201347.","journal-title":"J Comp Eff Res"},{"key":"964_CR168","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1186\/1471-2458-14-1144","volume":"14","author":"WG van Panhuis","year":"2014","unstructured":"van Panhuis WG, et al. A systematic review of barriers to data sharing in public health. BMC Public Health. 2014;14:1144.","journal-title":"BMC Public Health"},{"key":"964_CR169","volume-title":"Establishing incentives and changing cultures to support data access","author":"M Bobrow","year":"2014","unstructured":"Bobrow, M., et al. Establishing incentives and changing cultures to support data access. 2014; Available from: https:\/\/wellcome.ac.uk\/sites\/default\/files\/establishing-incentives-and-changing-cultures-to-support-data-access-eagda-may14.pdf. [cited 2019 January 4]."},{"issue":"3","key":"964_CR170","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1556264615594767","volume":"10","author":"S Bull","year":"2015","unstructured":"Bull S, Roberts N, Parker M. Views of ethical best practices in sharing individual-level data from medical and public Health Research: a systematic scoping review. J Empir Res Hum Res Ethics. 2015;10(3):225\u201338.","journal-title":"J Empir Res Hum Res Ethics"},{"key":"964_CR171","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41073-017-0028-9","volume":"2","author":"A Rowhani-Farid","year":"2017","unstructured":"Rowhani-Farid A, Allen M, Barnett AG. What incentives increase data sharing in health and medical research? A systematic review. Res Integr Peer Rev. 2017;2:4.","journal-title":"Res Integr Peer Rev"},{"issue":"4","key":"964_CR172","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ipm.2017.03.003","volume":"53","author":"Y Kim","year":"2017","unstructured":"Kim Y. Fostering scientists\u2019 data sharing behaviors via data repositories, journal supplements, and personal communication methods. Inf Process Manag. 2017;53(4):871\u201385.","journal-title":"Inf Process Manag"},{"key":"964_CR173","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jclinepi.2015.07.002","volume":"70","author":"C Hopkins","year":"2016","unstructured":"Hopkins C, et al. UK publicly funded clinical trials units supported a controlled access approach to share individual participant data but highlighted concerns. J Clin Epidemiol. 2016;70:17\u201325.","journal-title":"J Clin Epidemiol"},{"key":"964_CR174","doi-asserted-by":"publisher","unstructured":"Learned K, Durbin A, Currie R, Beale H, Lam DL, Goldstein T, Salama SR, Haussler D, Morozova O, Bjork I. A critical evaluation of genomic data sharing: Barriers to accessing pediatric cancer genomic datasets: a Treehouse Childhood Cancer Initiative experience [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017. Washington, DC. Philadelphia (PA): AACR; Cancer Res. 2017;77(13 Suppl):Abstract nr LB-338. https:\/\/doi.org\/10.1158\/1538-7445.AM2017-LB-338.","DOI":"10.1158\/1538-7445.AM2017-LB-338"},{"issue":"Pt A","key":"964_CR175","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cct.2015.06.012","volume":"45","author":"M Simmonds","year":"2015","unstructured":"Simmonds M, Stewart G, Stewart L. A decade of individual participant data meta-analyses: A review of current practice. Contemp Clin Trials. 2015;45(Pt A):76\u201383.","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"964_CR176","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/jrsm.1160","volume":"6","author":"TP Debray","year":"2015","unstructured":"Debray TP, et al. Get real in individual participant data (IPD) meta-analysis: a review of the methodology. Res Synth Methods. 2015;6(4):293\u2013309.","journal-title":"Res Synth Methods"},{"issue":"5","key":"964_CR177","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/ebmed-2017-110775","volume":"22","author":"E Rogozinska","year":"2017","unstructured":"Rogozinska E, et al. Meta-analysis using individual participant data from randomised trials: opportunities and limitations created by access to raw data. Evidence-Based Med. 2017;22(5):157\u201362.","journal-title":"Evidence-Based Med"},{"issue":"16","key":"964_CR178","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","volume":"313","author":"LA Stewart","year":"2015","unstructured":"Stewart LA, et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. JAMA. 2015;313(16):1657\u201365.","journal-title":"JAMA"},{"key":"964_CR179","volume-title":"SAS Clinical Trial Data Transparency","author":"SAS Institute","year":"2014","unstructured":"SAS Institute. SAS Clinical Trial Data Transparency. 2014; Available from: http:\/\/support.sas.com\/documentation\/onlinedoc\/clinicaltrial\/index.html. [cited 2014 July 20]."},{"key":"964_CR180","volume-title":"Multi-Sponsor Environment - SAS\u00ae Clinical Trial Data Transparency Version 2.3 User Guide","author":"SAS Institute","year":"2018","unstructured":"SAS Institute, Multi-Sponsor Environment - SAS\u00ae Clinical Trial Data Transparency Version 2.3 User Guide. 2018."},{"key":"964_CR181","unstructured":"Clinical Study Data Request. Access to Data 2018; Available from: https:\/\/clinicalstudydatarequest.com\/Help\/Help-Access-to-Data.aspx. [cited 2018 August 1]."},{"issue":"6","key":"964_CR182","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3122\/jabfm.2016.06.160198","volume":"29","author":"GA Mospan","year":"2016","unstructured":"Mospan GA, Wargo KA. Researchers\u2019 experience with clinical data sharing. J Am Board Fam Med. 2016;29(6):805\u20137.","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"964_CR183","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13063-017-1816-8","volume":"18","author":"L Mbuagbaw","year":"2017","unstructured":"Mbuagbaw L, et al. Challenges to complete and useful data sharing. Trials. 2017;18(1):71.","journal-title":"Trials"},{"issue":"1","key":"964_CR184","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12910-016-0153-x","volume":"17","author":"M Aitken","year":"2016","unstructured":"Aitken M, et al. Public responses to the sharing and linkage of health data for research purposes: a systematic review and thematic synthesis of qualitative studies. BMC Med Ethics. 2016;17(1):73.","journal-title":"BMC Med Ethics"},{"issue":"3","key":"964_CR185","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/pst.1615","volume":"13","author":"S Hughes","year":"2014","unstructured":"Hughes S, et al. Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach. Pharm Stat. 2014;13(3):179\u201383.","journal-title":"Pharm Stat"},{"key":"964_CR186","unstructured":"Committee on Strategies for Responsible Sharing of Clinical Trial Data, Board on Health Sciences Policy, and Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risk. Washington (DC): National Academies Press (US); 2015 Appendix B, Concepts and Methods for De-identifying Clinical Trial Data]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK285994\/."},{"key":"964_CR187","doi-asserted-by":"publisher","first-page":"h1139","DOI":"10.1136\/bmj.h1139","volume":"350","author":"KE Emam","year":"2015","unstructured":"Emam KE, Rodgers S, Malin B. Anonymising and sharing individual patient data. BMJ. 2015;350:h1139.","journal-title":"BMJ"},{"issue":"7","key":"964_CR188","doi-asserted-by":"publisher","first-page":"e1001855","DOI":"10.1371\/journal.pmed.1001855","volume":"12","author":"JF Tierney","year":"2015","unstructured":"Tierney JF, et al. Individual participant data (IPD) meta-analyses of randomised controlled trials: guidance on their use. PLoS Med. 2015;12(7):e1001855.","journal-title":"PLoS Med"},{"issue":"Supplement 1","key":"964_CR189","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12874-016-0170-y","volume":"16","author":"S Hollis","year":"2016","unstructured":"Hollis S, et al. Best practice for analysis of shared clinical trial data. BMC Med Res Methodol. 2016;16(Supplement 1):76.","journal-title":"BMC Med Res Methodol"},{"key":"964_CR190","volume-title":"About AllTrials","author":"AllTrials","year":"2014","unstructured":"AllTrials. About AllTrials. 2014; Available from: http:\/\/www.alltrials.net\/find-out-more\/about-alltrials\/. [cited 2018 August 1]."},{"key":"964_CR191","volume-title":"Data transparency","author":"GlaxoSmithKline","year":"2014","unstructured":"GlaxoSmithKline. Data transparency. 2014; Available from: https:\/\/www.gsk.com\/en-gb\/behind-the-science\/innovation\/data-transparency\/. [cited 2018 August 1]."},{"issue":"12","key":"964_CR192","doi-asserted-by":"publisher","first-page":"877","DOI":"10.7326\/0003-4819-158-12-201306180-00005","volume":"158","author":"MC Simmonds","year":"2013","unstructured":"Simmonds MC, et al. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med. 2013;158(12):877\u201389.","journal-title":"Ann Intern Med"},{"issue":"12","key":"964_CR193","doi-asserted-by":"publisher","first-page":"890","DOI":"10.7326\/0003-4819-158-12-201306180-00006","volume":"158","author":"R Fu","year":"2013","unstructured":"Fu R, et al. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann Intern Med. 2013;158(12):890\u2013902.","journal-title":"Ann Intern Med"},{"issue":"12","key":"964_CR194","doi-asserted-by":"publisher","first-page":"910","DOI":"10.7326\/0003-4819-158-12-201306180-00009","volume":"158","author":"HM Krumholz","year":"2013","unstructured":"Krumholz HM, et al. A historic moment for open science: the Yale University open data access project and medtronic. Ann Intern Med. 2013;158(12):910\u20131.","journal-title":"Ann Intern Med"},{"key":"964_CR195","doi-asserted-by":"publisher","first-page":"f6927","DOI":"10.1136\/bmj.f6927","volume":"347","author":"A Hrobjartsson","year":"2013","unstructured":"Hrobjartsson A. Why did it take 19 months to retrieve clinical trial data from a non-profit organisation? BMJ. 2013;347:f6927.","journal-title":"BMJ"},{"issue":"9","key":"964_CR196","doi-asserted-by":"publisher","first-page":"e7078","DOI":"10.1371\/journal.pone.0007078","volume":"4","author":"CJ Savage","year":"2009","unstructured":"Savage CJ, Vickers AJ. Empirical study of data sharing by authors publishing in PLoS journals. PLoS One. 2009;4(9):e7078.","journal-title":"PLoS One"},{"key":"964_CR197","doi-asserted-by":"publisher","first-page":"h5087","DOI":"10.1136\/bmj.h5087","volume":"351","author":"J Filippon","year":"2015","unstructured":"Filippon J. Slow and costly access to anonymised patient data impedes academic research. BMJ. 2015;351:h5087.","journal-title":"BMJ"},{"issue":"5","key":"964_CR198","doi-asserted-by":"publisher","first-page":"e97886","DOI":"10.1371\/journal.pone.0097886","volume":"9","author":"C Tudur Smith","year":"2014","unstructured":"Tudur Smith C, et al. Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository. PLoS One. 2014;9(5):e97886.","journal-title":"PLoS One"},{"issue":"4","key":"964_CR199","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/1740774518769655","volume":"15","author":"V Huser","year":"2018","unstructured":"Huser V, Shmueli-Blumberg D. Data sharing platforms for de-identified data from human clinical trials. Clinical Trials. 2018;15(4):413\u201323.","journal-title":"Clinical Trials"},{"issue":"9","key":"964_CR200","doi-asserted-by":"publisher","first-page":"e0184491","DOI":"10.1371\/journal.pone.0184491","volume":"12","author":"D So","year":"2017","unstructured":"So D, Knoppers BM. Ethics approval in applications for open-access clinical trial data: An analysis of researcher statements to clinicalstudydatarequest.com. PLoS One. 2017;12(9):e0184491.","journal-title":"PLoS One"},{"issue":"1","key":"964_CR201","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13063-015-0604-6","volume":"16","author":"MR Sydes","year":"2015","unstructured":"Sydes MR, et al. Sharing data from clinical trials: The rationale for a controlled access approach. Trials. 2015;16(1):104.","journal-title":"Trials"},{"issue":"5","key":"964_CR202","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1634\/theoncologist.2014-0431","volume":"20","author":"AK Green","year":"2015","unstructured":"Green AK, et al. The project data sphere initiative: accelerating cancer research by sharing data. Oncologist. 2015;20(5):464\u201372.","journal-title":"Oncologist"},{"issue":"1_suppl","key":"964_CR203","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/1740774518755058","volume":"15","author":"HG Eichler","year":"2018","unstructured":"Eichler HG, Sweeney F. The evolution of clinical trials: Can we address the challenges of the future? Clin Trials. 2018;15(1_suppl):27\u201332.","journal-title":"Clin Trials"},{"issue":"2","key":"964_CR204","doi-asserted-by":"publisher","first-page":"97","DOI":"10.12980\/apjtd.7.2017D6-357","volume":"7","author":"A Khusro","year":"2017","unstructured":"Khusro A, Aarti C. TB-PACTS: a fresh emphatic data sharing approach. Asian Pac J Trop Dis. 2017;7(2):97\u20138.","journal-title":"Asian Pac J Trop Dis"},{"issue":"12","key":"964_CR205","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1056\/NEJMsb1702054","volume":"376","author":"MM Bertagnolli","year":"2017","unstructured":"Bertagnolli MM, et al. Advantages of a truly open-access data-sharing model. N Engl J Med. 2017;376(12):1178\u201381.","journal-title":"N Engl J Med"},{"issue":"3","key":"964_CR206","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jaci.2016.05.034","volume":"138","author":"AL Asare","year":"2016","unstructured":"Asare AL, et al. Clinical trial data access: opening doors with TrialShare. J Allergy Clin Immunol. 2016;138(3):724\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"964_CR207","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/ACM.0000000000001028","volume":"91","author":"DE Zinner","year":"2016","unstructured":"Zinner DE, Pham-Kanter G, Campbell EG. The changing nature of scientific sharing and withholding in academic life sciences Research: trends from National Surveys in 2000 and 2013. Acad Med. 2016;91(3):433\u201340.","journal-title":"Acad Med"},{"issue":"10","key":"964_CR208","doi-asserted-by":"publisher","first-page":"e011784","DOI":"10.1136\/bmjopen-2016-011784","volume":"6","author":"A Rowhani-Farid","year":"2016","unstructured":"Rowhani-Farid A, Barnett AG. Has open data arrived at the British medical journal (BMJ)? An observational study. BMJ Open. 2016;6(10):e011784.","journal-title":"BMJ Open"},{"issue":"17","key":"964_CR209","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMp1610336","volume":"375","author":"BL Strom","year":"2016","unstructured":"Strom BL, et al. Data sharing - is the juice worth the squeeze? N Engl J Med. 2016;375(17):1608\u20139.","journal-title":"N Engl J Med"},{"issue":"26","key":"964_CR210","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1056\/NEJMp1409464","volume":"371","author":"S Bonini","year":"2014","unstructured":"Bonini S, et al. Transparency and the European medicines agency--sharing of clinical trial data. N Engl J Med. 2014;371(26):2452\u20135.","journal-title":"N Engl J Med"},{"issue":"3","key":"964_CR211","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1056\/NEJMp1415160","volume":"372","author":"JM Drazen","year":"2015","unstructured":"Drazen JM. Sharing individual patient data from clinical trials. N Engl J Med. 2015;372(3):201\u20132.","journal-title":"N Engl J Med"},{"issue":"5","key":"964_CR212","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1056\/NEJMp1605654","volume":"375","author":"International Consortium of Investigators for Fairness in Trial Data, S","year":"2016","unstructured":"International Consortium of Investigators for Fairness in Trial Data, S, et al. Toward Fairness in Data Sharing. N Engl J Med. 2016;375(5):405\u20137.","journal-title":"N Engl J Med"},{"issue":"6","key":"964_CR213","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jama.2016.8797","volume":"316","author":"AM Navar","year":"2016","unstructured":"Navar AM, Pencina MJ, Peterson ED. Open access platforms for sharing clinical trial data--reply. JAMA. 2016;316(6):666\u20137.","journal-title":"JAMA"},{"issue":"6","key":"964_CR214","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jama.2016.8794","volume":"316","author":"JS Ross","year":"2016","unstructured":"Ross JS, Krumholz HM. Open access platforms for sharing clinical trial data. JAMA. 2016;316(6):666.","journal-title":"JAMA"},{"issue":"12","key":"964_CR215","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1001\/jama.2016.2374","volume":"315","author":"AM Navar","year":"2016","unstructured":"Navar AM, et al. Use of open access platforms for clinical trial data. JAMA. 2016;315(12):1283\u20134.","journal-title":"JAMA"},{"issue":"7","key":"964_CR216","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/gim.2015.138","volume":"18","author":"NA Garrison","year":"2016","unstructured":"Garrison NA, et al. A systematic literature review of individuals\u2019 perspectives on broad consent and data sharing in the United States. Genet Med. 2016;18(7):663\u201371.","journal-title":"Genet Med"},{"key":"964_CR217","volume-title":"Aegerion Pharmaceuticals","author":"Vivli","year":"2019","unstructured":"Vivli. Aegerion Pharmaceuticals. 2019; Available from: https:\/\/vivli.org\/ourmember\/aegerion-pharmaceuticals\/. [cited 2019 March 1]."},{"key":"964_CR218","volume-title":"Commitment letter","author":"Esteve","year":"2014","unstructured":"Esteve. Commitment letter. 2014; Available from: https:\/\/www.efpia.eu\/media\/25446\/esteve.pdf. [cited 2019 March 14]."},{"key":"964_CR219","volume-title":"Transparency and trust","author":"Ipsen","year":"2019","unstructured":"Ipsen. Transparency and trust. 2019; Available from: https:\/\/www.ipsen.com\/commitments\/transparency-and-trust\/clinical-trials\/. [cited 2019 March 14]."},{"key":"964_CR220","volume-title":"Vivli Platform Process at a Glance","author":"Vivli.org","year":"2020","unstructured":"Vivli.org. Vivli Platform Process at a Glance 2020. Available from: https:\/\/vivli.org\/about\/data-request-review-process\/. [cited 2020 March 17]."}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-020-00964-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-020-00964-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-020-00964-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T19:37:58Z","timestamp":1620761878000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-020-00964-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":220,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["964"],"URL":"https:\/\/doi.org\/10.1186\/s12874-020-00964-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.16277\/v1","asserted-by":"object"}]},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"27 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Clarke reports being co-convenor of the Cochrane Individual Participant Data Meta-analysis Methods Group and involved in several IPDMAs funded by a variety of research funders. Dr. Garcia reports grants and personal fees from Incyte, grants from Bayer, grants, personal fees and non-financial support from Janssen, personal fees and non-financial support from Seattle Genetics, grants from Daiichi Sankyo, outside the submitted work. Dr. Di Nisio reports personal fees from Bayer, personal fees from BMS-Pfizer, personal fees from Leo Pharma, personal fees from Aspen, personal fees from Daiichi Sankyo, outside the submitted work. Dr. Noble reports grants from Leo Pharma, personal fees from Bayer, personal fees from Daiichi Sankyo, outside the submitted work. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}